Gene Editing & Modulation: A Usage & Attitude Study

A prominent consulting firm sought to deepen its understanding of the usage patterns and attitudes toward gene editing and gene modulation tools among life sciences researchers. To achieve this, they partnered with Phronesis Partners to conduct a comprehensive Usage & Attitude (U&A) study.

Objective

The consulting firm aimed to gather detailed feedback from life sciences researchers specializing in gene editing and gene modulation.

Their primary objectives were to:

• Understand the supply chain dynamics of instruments and reagents

• Analyze usage patterns of RNA interference (RNAi) reagents for gene modulation and CRISPR reagents for gene editing

These insights were intended to inform their client, a leading provider of research and clinical application tools, to optimize their product offerings and better serve the scientific community.

Solution

Phronesis Partners implemented a structured approach to meet the study's objectives:

• Target Identification: We identified relevant institutions, companies, and organizations across key regions, including the USA, UK, Netherlands, Finland, Sweden, India, Singapore, and Australia

• Respondent Recruitment: Utilizing our proprietary panel, supplemented by custom telephonic outreach, we recruited qualified respondents fitting the study's criteria

• Primary Research Execution: We conducted a quantitative survey targeting various respondent profiles, ensuring comprehensive data collection aligned with the study's goals

Impact

The study provided the consulting firm with valuable insights, enabling them to:

• Gain a clearer understanding of the supply chain for instruments and reagents in the gene editing and modulation sectors
• Analyze and interpret usage patterns of RNAi and CRISPR reagents among researchers

These outcomes equipped the firm with the necessary information to advise their client on product development and marketing strategies, ultimately enhancing their market position and better addressing the needs of the scientific community.